Anticancer properties of medicinal plants and their bioactive compounds against breast cancer: a review on recent investigations

Environ Sci Pollut Res Int. 2022 Apr;29(17):24411-24444. doi: 10.1007/s11356-021-17795-7. Epub 2022 Jan 22.

Abstract

Breast cancer (BC) is one of the most common and recurring diseases and the second leading cause of death in women. Despite prevention, diagnostics, and therapeutic options such as radiation therapy and chemotherapy, the number of occurrences increases every year. Therefore, novel therapeutic drugs targeting specifically different checkpoints should be developed against breast cancer. Among drugs that can be developed to treat breast cancer, natural products, such as plant-derived compounds, showed significant anti-breast cancer properties. These substances belong to different chemical classes such as flavonoids, terpenoids, phenolic acids, and alkaloids. They exert their in vitro and in vivo cytotoxic activities against breast cancer cell lines via different mechanisms, including the inhibition of extrinsic and intrinsic apoptotic pathways, the arrest of the cell cycle, and the activation of autophagy. Moreover, they also exhibit anti-angiogenesis and antimetastatic action. Moreover, chemoprevention effects of these bioactive compounds were signaled only for certain drugs. Therefore, the aim of this review is to highlight the pharmacological actions of medicinal plants and their bioactive compounds on breast cancer. Moreover, the role of these substances in breast cancer chemoprevention was also discussed.

Keywords: Bioactive compounds; Breast cancer; Herbal medicine; Medicinal plant.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Apoptosis
  • Biological Products* / pharmacology
  • Breast Neoplasms* / drug therapy
  • Female
  • Humans
  • Plants, Medicinal* / chemistry

Substances

  • Antineoplastic Agents
  • Biological Products